期刊文献+

阿维A联合复方氟美松治疗寻常性银屑病随机双盲研究

Random Double Blind Contrast Study on Treatment of Psoriasis Vulgaris by Acitretin Capsules and Orsalin Ointment
原文传递
导出
摘要 目的:研究阿维A联合复方氟美松治疗寻常型银屑病的临床疗效及安全性。方法:采用随机双盲对照的分析方法,将入选患者随机分为治疗组和对照组,治疗组接受阿维A胶囊和复方氟美松软膏联合治疗,对照组应用复方氨肽素和氯倍他索软膏联合治疗。结果:治疗组临床治愈率和有效率优于对照组,不良反应发生率差异无统计学意义(P>0.05)。结论:阿维A联合复方氟美松治疗寻常型银屑病安全有效。 Objective:To study the efficacy and safety of acitretin capsules and orsalin ointment in the treatment of psoriasis vulgaris. Methods:The random double blind contrast was adapted,the cases were divided into 2 groups randomly: the treatment group was received acitretin capsules and orsalin ointment, the control group was received compound antaisu plan and clobetasol propionate. Results: After treatment for eight weeks, the efficient and the cure of the treatment group was superior to the control group. The incidence of adverse reactions was no significant difference ( P〉0.05). Conclusions:The results of the treatment of psoriasis vulgaris of aeitretin capsules and orsalin ointment is safe and valid.
作者 郭猛 徐春华
出处 《慢性病学杂志》 2010年第1期13-14,共2页 Chronic Pathematology Journal
关键词 阿维A/治疗应用 氟米松/治疗应用 银屑病/药物疗法 药物疗法 联合 Aeitretin/therapeutic use Flumethasone/therapeutic use Psoriasis/drug therapy Drug Therapy, Combination
  • 相关文献

参考文献5

二级参考文献22

  • 1[1]Christophers E. Psoriasis-epidemiology and clinical spectrum [J]. Clin Exp Dermatol, 2001, 26:314-420.
  • 2[2]Cunliffe WJ, Berth-Jones J, Claudy A, et al. Comparative study of calcipotriol ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris [J]. J Am Aead Dermatol, 1992, 26:736-743.
  • 3[3]Harari M, Shani J, Hristakieva E, et al. Clinical evaluation of a more rapid and sensitive psoriasis assessment severity score, and its comparison with the classic method of psoriasis area and severity index (PASI), before and after elimatotherapy at the dead-sea[J]. Int J Dermatol, 2000,39:913-918.
  • 4[4]Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents[J]. J Am Acad Dermatol, 2002,46:1-23.
  • 5[5]Bagot M, Charue D, Lescs M C, et al. Immunosuppressive effects of 1,25-dihydroxyvitamin D3 and its analogue calcipotriol on epi-dermal cells[J]. Br J De rmatol, 1994,130:424-431.
  • 6[6]Manggau M, Kim D S, Ruwisch L, et al. 1,25-Dihydroxyvitamin D3 protects human keratinoeytes from apoptosis by the formation of sphingosine-1-phosphate [J]. J Invest Dermatol, 2001,117: 1241-1249.
  • 7[7]Mattner F, Smiroldo S, Galbiati F, et al. Inhibition of Th1 devel opment and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercacemie analogue of 1,25-dihy droxyvitaminD3[J]. Eur J Immunol, 2000,30:498-508.
  • 8[8]Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differen tiation,maturat ion,and function of human monocyte-derived den dritic cells[J]. J Immunol, 2000,164:4443-4451.
  • 9[9]Barrat FJ, Cua DJ, Boonstra A, et al. In vitro generation of inter leukin-10-producing regulatory CD4+ T cells is induced by im munosuppressive drugs and inhibited by T helper type 1 Th1 and Th2-induceing cytokine[J]. J Exp Med,2002,195:603-616.
  • 10[10]Jirapongsananuruk O, Melamed I, Leung D Y M. Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and cor ticteroids on Th1, but not TH2,responses[J]. J Allergy Clin Immunol, 2000,106:981-985.

共引文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部